Medicare Advantage enrollees experience lower rates of hospital admission and lower rates of expensive and ineffective medical procedures in the last few months of life.
Category: Policy & Legislation
Wednesday Links
- Life expectancy for men in the U.S. falls to 73 years — six years less than for women.
- Noah Smith lauds Singapore but neglects to mention Medisave accounts.
- What discount rate should be used in evaluating changes in health policies?
- Should medical screenings be based on cost/benefit analysis or on the patient’s willingness to pay?
- A tribute to Vernon Smith – long time friend of the Goodman Institute.
- Does the case for a free society depend on the existence of free will?
Should Employers Fund Rare Disease Research and Therapies?
Included in Friday Links (November 10) was the title, “Would coverage for gene therapies make employer-based health insurance unaffordable?” That raises an important question: How much should employers (and employees) be required to pay for hyper-expensive therapies very few people need? A related question: should the purpose of employee health coverage be to recruit and retain workers or fund rare disease research and therapies?
Monday Links
- Are apprenticeships a viable alternative to higher education? If so, why does government subsidize the latter and not the former?
- The IRA bill has already stopped the development of one cancer drug and may be delaying many more.
- Why do new drugs have such bizarre names? It’s bureaucracy gone amok.
- Study: thunderstorms cause asthma attacks.